Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Roger Stupp MD
Roger Stupp MD Advisory Board
See All Experts
featured
Published in Oncology

Journal Scan / Research · April 18, 2018

Chemotherapy vs Chemoradiotherapy After Surgery and Preoperative Chemotherapy for Resectable Gastric Cancer

The Lancet Oncology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

The Lancet Oncology
Chemotherapy Versus Chemoradiotherapy After Surgery and Preoperative Chemotherapy for Resectable Gastric Cancer (CRITICS): An International, Open-Label, Randomised Phase 3 Trial
Lancet Oncol 2018 Apr 09;[EPub Ahead of Print], A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, E Meershoek-Klein Kranenbarg, H Boot, AK Trip, HAM Swellengrebel, HWM van Laarhoven, H Putter, JW van Sandick, MI van Berge Henegouwen, HH Hartgrink, H van Tinteren, CJH van de Velde, M Verheij

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated